Food and Drug Administration
“Real-time Outcome Labels & Treatment Rankings”
— Wishonia, Planetary Systems Engineer
Report Card
Food and Drug Administration
FDA budget increased 454% while the cost to develop a new drug increased 287%. The agency meant to make drugs accessible made them more expensive.
“The FDA's budget quintupled and drug development costs quadrupled. That is not regulation. That is a protection racket with a government seal.”
— Wishonia
What They Optimize For
8.2 years from safety proof to patient access. The delay IS the business model — it protects pharma exclusivity, not patients.
Approving a drug that harms 100 = career over. Blocking a drug that could save 100,000 = nobody notices. The FDA optimizes for the first.
75% of drug review costs are paid by the companies being reviewed. The regulator is funded by the regulated.
Zero. If it's proven safe, patients can access it immediately.
Every treatment gets a continuously-updated label showing effectiveness, side effects, and optimal dosage from real-world data.
For any condition, see all treatments ranked by effectiveness, safety, and confidence — updated in real-time.
Spending vs Outcomes
🏥 Food and Drug Administration
Protect public health by ensuring safety and efficacy of drugs and food
2004 Vioxx withdrawn — FDA knew about cardiac risks for years, approved anyway ↗
2003 Medicare Part D signed — pharma lobbies a BAN on government negotiating drug prices ↗
2024 Same drug: Insulin US $300, Canada $30. Humira US $80K, UK $15K. ↗
FDA budget increased 454% while the cost to develop a new drug increased 287%. The agency meant to make drugs accessible made them more expensive.
What They Cost You
Average delay from safety proof to FDA approval
Estimated deaths waiting for treatments already proven safe
Average cost to bring one drug to market through the FDA process
What Replaces Them
8.2-year queue → real-time outcome data
// The dFDA replaces the approval queue with continuous evidence:
// Stage 1: Real-world evidence from existing data ($1/patient)
// Stage 2: Pragmatic trials in routine care ($929/patient)
// Every treatment gets an Outcome Label — updated in real-time
// See: dfda.earth for the full specificationInstead of a binary approve/reject gate, treatments get continuously-updated Outcome Labels showing what actually happens when real humans take them. Doctors and patients see effectiveness, side effects, and confidence levels — from millions of data points, not a single trial of 200 people.
The Savings
The value is measured in lives, not dollars. 102 million people died waiting for treatments that were already proven safe.
“Your FDA has two speeds: 'not yet' and 'too late.' The queue exists because a bureaucrat who approves a drug that hurts 100 people gets fired, but a bureaucrat who blocks a drug that could save 100,000 gets promoted. The incentives are perfect — for killing people slowly.”
— Wishonia
See the Optimized Version
Every Earth agency has a replacement that runs on code instead of bureaucracy. Fund the campaign. See the full system. Set your priorities.